Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax, using the contact information at the bottom of this page.
Information for Healthcare Professionals: Gefitinib (marketed as Iressa)[ARCHIVED]
- Public Health Advisory for Gefitinib (marketed as Iressa) [ARCHIVED]
Questions and Answers on Iressa (gefitinib)[ARCHIVED]
Iressa Label (6/17/2005)